(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.74%) $78.69
(2.57%) $2.20
(1.11%) $2 334.30
(3.71%) $27.68
(0.18%) $967.05
(-0.03%) $0.929
(-0.36%) $10.84
(-0.13%) $0.796
(-0.12%) $91.35
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 6.29%
0.18% $ 28.40
@ $17.99
Wydano: 14 vas. 2024 @ 22:07
Zwrot: 57.87%
Poprzedni sygnał: vas. 14 - 21:44
Poprzedni sygnał:
Zwrot: 1.47 %
Live Chart Being Loaded With Signals
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 762 513 |
Średni wolumen | 694 375 |
Kapitalizacja rynkowa | 1.22B |
EPS | $0 ( 2024-03-14 ) |
Następna data zysków | ( $-0.900 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.70 |
ATR14 | $0.0660 (0.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-29 | Fenton Mary Kay | Buy | 200 000 | Stock Option (Right to Buy) |
2024-04-29 | Fenton Mary Kay | Buy | 0 | |
2024-03-29 | Nguyen Nate | Sell | 0 | Common Stock |
2024-03-29 | Nguyen Nate | Sell | 0 | Common Stock |
2024-03-29 | Nguyen Nate | Sell | 26 750 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-16.93 |
Last 98 transactions |
Buy: 2 707 515 | Sell: 6 664 307 |
Wolumen Korelacja
Cullinan Oncology, LLC Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
BNIXU | 0.96 |
SGEN | 0.914 |
ATVI | 0.879 |
STAY | 0.876 |
VLATU | 0.874 |
TIOAU | 0.872 |
FTIV | 0.871 |
RADI | 0.87 |
NTIC | 0.868 |
FOCS | 0.867 |
10 Najbardziej negatywne korelacje | |
---|---|
RMRM | -0.924 |
NMTR | -0.915 |
TLGT | -0.887 |
CETX | -0.882 |
EVOK | -0.875 |
GLBS | -0.874 |
SBAC | -0.872 |
IDBA | -0.871 |
BFI | -0.869 |
WINT | -0.869 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cullinan Oncology, LLC Korelacja - Waluta/Towar
Cullinan Oncology, LLC Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-310 000 (0.00 %) |
EPS: | $-3.69 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-310 000 (0.00 %) |
EPS: | $-3.69 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-93 000.00 (0.00 %) |
EPS: | $2.46 |
FY | 2021 |
Przychody: | $18 943.00 |
Zysk brutto: | $18 943.00 (100.00 %) |
EPS: | $-0.00157 |
Financial Reports:
No articles found.
Cullinan Oncology, LLC
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its preclinical products include CLN-049, a humanized bispecific antibody for the treatment of acute myeloid leukemia; CLN-619, a monoclonal antibody for the treatment of solid tumors; CLN-617, a fusion protein for the treatment of solid tumors; CLN-978, a T cell engaging antibody for B-cell malignancies; Opal, a bispecific fusion protein to block the PD-1 axis, and to activate the 4-IBB/CD137 pathway on T cells in tumors; and Jade, a cell therapy to target a novel senescence and cancer-related protein. The company has collaboration agreements with Cullinan Pearl Corp. to develop, manufacture, and commercialize CLN-081 and products containing CLN-081; and Adimab, LLC to discover and/or optimize antibodies. Cullinan Oncology, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej